UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+8.87%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$4.63B
AUM Growth
-$759M
(-14%)
Cap. Flow
-$1.04B
Cap. Flow
% of AUM
-22.38%
Top 10 Holdings %
Top 10 Hldgs %
24.76%
Holding
534
New
130
Increased
86
Reduced
105
Closed
144
Top Buys
| 1 |
LNKD
LinkedIn Corporation
LNKD
|
$229M |
| 2 |
STJ
St Jude Medical
STJ
|
$99.5M |
| 3 |
EMC
EMC CORPORATION
EMC
|
$79.7M |
| 4 |
Charter Communications
CHTR
|
$47.4M |
| 5 |
AXLL
AXIALL CORP COM STK (DE)
AXLL
|
$39.2M |
Top Sells
| 1 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
$122M |
| 2 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
$119M |
| 3 |
AGN
Allergan plc
AGN
|
$73.4M |
| 4 |
Charles Schwab
SCHW
|
$71.1M |
| 5 |
Mondelez International
MDLZ
|
$65.6M |
Sector Composition
| 1 | Consumer Staples | 14.03% |
| 2 | Technology | 13.13% |
| 3 | Industrials | 11.75% |
| 4 | Consumer Discretionary | 11.65% |
| 5 | Communication Services | 11.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GPOR
301
DELISTED
Gulfport Energy Corp.
GPOR
| $582K | 0.01% |
18,626
-27,367
| -60% | -$855K |
|
|
PRTK
302
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $556K | 0.01% |
+40,000
| New | +$556K |
|
303
SCYNEXIS
SCYX
$37.3M
| $542K | 0.01% |
+25,000
| New | +$542K |
|
|
MOBL
304
DELISTED
MobileIron, Inc.
MOBL
| $535K | 0.01% |
175,314
+41,694
| +31% | +$127K |
|
305
Marathon Petroleum
MPC
$54.8B
| $531K | 0.01% |
+14,000
| New | +$531K |
|
306
NNN REIT
NNN
$8.18B
| $517K | 0.01% |
+10,000
| New | +$517K |
|
307
Coterra Energy
CTRA
$18.3B
| $515K | 0.01% |
20,000
| – | – |
|
308
Ring Energy
REI
$207M
| $494K | 0.01% |
+56,029
| New | +$494K |
|
|
TEN
309
Tsakos Energy Navigation Ltd.
TEN
$669M
| $469K | 0.01% |
+20,000
| New | +$469K |
|
310
Realty Income
O
$54.2B
| $464K | 0.01% |
+6,897
| New | +$464K |
|
|
OXFD
311
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $456K | 0.01% |
50,705
-5,595
| -10% | -$50.3K |
|
312
ADMA Biologics
ADMA
$4.03B
| $446K | 0.01% |
75,000
+40,000
| +114% | +$238K |
|
|
TESO
313
DELISTED
Tesco Corp
TESO
| $430K | 0.01% |
+64,337
| New | +$430K |
|
|
RPTP
314
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $403K | 0.01% |
75,000
+55,274
| +280% | +$297K |
|
315
Matador Resources
MTDR
$6.01B
| $396K | 0.01% |
20,000
-98,000
| -83% | -$1.94M |
|
316
Enviri
NVRI
$948M
| $381K | 0.01% |
57,310
-663,684
| -92% | -$4.41M |
|
|
IVTY
317
DELISTED
Invuity, Inc
IVTY
| $381K | 0.01% |
40,000
-35,000
| -47% | -$333K |
|
|
CLCD
318
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| $368K | 0.01% |
44,994
-45,200
| -50% | -$370K |
|
|
CHK
319
DELISTED
Chesapeake Energy Corporation
CHK
| $360K | 0.01% |
+420
| New | +$360K |
|
320
Amicus Therapeutics
FOLD
$2.46B
| $324K | 0.01% |
+59,387
| New | +$324K |
|
|
GCVRZ
321
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $297K | 0.01% |
1,238,077
+19,798
| +2% | +$4.75K |
|
322
Choice Hotels
CHH
$5.41B
| $295K | 0.01% |
+6,187
| New | +$295K |
|
323
Corvus Pharmaceuticals
CRVS
$459M
| $285K | 0.01% |
20,000
-40,000
| -67% | -$570K |
|
|
GNMX
324
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $278K | 0.01% |
+50,000
| New | +$278K |
|
|
INVN
325
DELISTED
Invensense Inc
INVN
| $205K | ﹤0.01% |
33,385
+8,385
| +34% | +$51.5K |
|